BILCAP Trial 

A randomised clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following surgery for biliary tract cancer.

Trial Status Open

Aim To investigate the role of adjuvant chemotherapy with capecitabine following surgical resection of a biliary tract cancer.

BILCAP is an NCRN trial supported by Cancer Research UK.

If you are a Health Care Professional and would like access to the section of the site for Health Care Professionals and/or would like to be considered for participation as a Local Investigator for BILCAP, please contact us at BILCAP@trials.bham.ac.uk

The Clinical Trials Unit at the Cancer Research UK, Institute of Cancer Studies stands comfortably between the Pan Birmingham network of Hospitals that serve a population of over 5,000,000 people and a large basic science research group of over 200 researchers situated at the Institute of Cancer Studies